Theratechnologies (TH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 02-2024 | 11-2023 | 08-2023 | 05-2023 | 02-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 517 | 576 | 868 | 932 | 939 |
| Income taxes - deferred | 110 | 73 | 126 | 126 | 96 |
| Accounts receivable | 3,051 | -4,450 | 4,462 | -3,142 | 2,013 |
| Accounts payable and accrued liabilities | 1,422 | N/A | -2,947 | N/A | N/A |
| Other Working Capital | 1,421 | -5,470 | 6,599 | 4,643 | 2,361 |
| Other Operating Activity | -8,229 | 5,165 | -3,779 | -6,121 | -8,748 |
| Operating Cash Flow | $-1,708 | $-4,106 | $5,329 | $-3,562 | $-3,339 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -15 | -81 | -222 |
| Purchase Of Investment | 0 | 0 | 0 | 0 | -104 |
| Sale Of Investment | 134 | 1,642 | 573 | 815 | N/A |
| Other Investing Activity | 0 | -1,500 | 0 | 0 | 0 |
| Investing Cash Flow | $134 | $142 | $558 | $734 | $-326 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | -7,452 | N/A | N/A |
| Debt Repayment | -122 | -119 | -112 | -96 | -125 |
| Other Financing Activity | -153 | 23,212 | -350 | -146 | -37 |
| Financing Cash Flow | $-275 | $23,093 | $-7,914 | $-242 | $-162 |
| Exchange Rate Effect | -8 | 2 | 36 | 4 | -6 |
| Beginning Cash Position | 34,097 | 14,966 | 16,957 | 20,023 | 23,856 |
| End Cash Position | 32,240 | 34,097 | 14,966 | 16,957 | 20,023 |
| Net Cash Flow | $-1,849 | $19,129 | $-2,027 | $-3,070 | $-3,827 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,708 | -4,106 | 5,329 | -3,562 | -3,339 |
| Capital Expenditure | N/A | -1,500 | -15 | -81 | -222 |
| Free Cash Flow | -1,708 | -5,606 | 5,314 | -3,643 | -3,561 |